Search results
30 lis 2020 · The diagnosis of acute babesiosis cannot be confirmed solely by the presence of Babesia antibody in a serum sample collected at a single time point. Treatment with a combination of atovaquone plus azithromycin for 7 to 10 days achieves cure in most cases [ 32 , 37–39 ].
13 lut 2024 · For ill patients, treatment usually involves at least a 7- to 10-day course of two prescription medications; often the duration of treatment is longer in immunocompromised patients. The typical combinations are:
26 paź 2023 · Babesia venatorum and Babesia crassa-like infections are endemic in northeastern China. The treatment and prevention of babesiosis will be reviewed here. The clinical manifestations, diagnosis, microbiology, epidemiology, and pathogenesis of babesiosis are discussed separately.
When oral azithromycin is used, a higher dose (500 to 1000 mg orally once daily) may be administered. Highly immunocompromised patients should be treated for at least 6 consecutive weeks, including 2 final weeks during which parasites are no longer detected on peripheral blood smear.
1 kwi 2021 · First line: Atovaquone 20 mg/kg/dose (up to 750 mg) q12h PO plus azithromycin 10 mg/kg/dose (up to 500 mg) q24h IV until symptoms improve, then convert to step-down therapy
27 sty 2021 · For immunocompetent patients, we recommend monitoring Babesia parasitemia during treatment of acute illness using peripheral blood smears but recommend against testing for parasitemia once symptoms have resolved (strong recommendation, moderate-quality evidence).
1 lis 2006 · The dosage regimen of atovaquone plus azithromycin for adults is atovaquone, 750 mg orally every 12 h, and azithromycin, 500–1000 mg on day 1 and 250 mg orally once per day thereafter. For immunocompromised patients with babesiosis, higher doses of azithromycin (600–1000 mg per day) may be used.
